References
Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med. 2006;354(5):483–95.
Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Acad Res Consort Circulation. 2007;115(17):2344–51.
Otsuka F, Nakano M, Ladich E, Kolodgie FD, Virmani R. Pathologic etiologies of late and very late stent thrombosis following first-generation drug-eluting stent placement. Thrombosis. 2012;2012:608593.
Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115(18):2426–34.
De la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, de Pérez Prado A, et al. Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2. JACC Cardiovasc Interv. 2010;3(9):909–11.
Schinkel AF, Barlis P, van Beusekom HM, Serruys PW, Regar E. Optical coherence tomography findings in very late (4 years) paclitaxel-eluting stent thrombosis. JACC Cardiovasc Interv. 2008;1(4):449–51.
Joyal D, Rudski L. Sirolimus-eluting stent thrombosis several years after clopidogrel discontinuation. J Invasive Cardiol. 2007;19(9):E265–7.
Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyakazi S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher registry. Circulation. 2012;125(4):584–91.
Taylor-Sutton JE, Kim MC. Very late stent thrombosis approximately 7 years after deployment and one-week cessation of dual antiplatelet therapy. J Invasive Cardiol. 2011;23(12):E273–6.
Spagnoli V, Veugeois A, Caussin C, Amabile N. Extremely late drug-eluting stent thrombosis related to uncovered struts: the phantom menace. Eur Heart J. 2013;34(31):2428.
Siddiqi OK, Faxon DP. Very late stent thrombosis: current concepts. Curr Opin Cardiol. 2012;27(6):634–41.
Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113(8):1108–13.
Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293(17):2126–30.
Lee CW, Kang SJ, Park DW, Lee SH, Kim YH, Kim JJ, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol. 2010;55(18):1936–42.
Costa MA, Sabate M, Angiolillo DJ, Jimenez-Quevedo P, Teirstein P, Carter A, et al. Intravascular ultrasound characterization of the “black hole” phenomenon after drug-eluting stent implantation. Am J Cardiol. 2006;97(2):203–6.
Zhang T, Shen L, Hu L, He B. Optimal duration of dual-antiplatelet therapy following drug-eluting stent implantation: a meta-analysis. J Clin Pharmacol. 2013;53(3):345–51.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
12928_2014_270_MOESM1_ESM.avi
Video 1: initial left anterior descending artery angiography, showing thrombotic content at proximal edge and middle stent segment (AVI 1371 kb)
12928_2014_270_MOESM2_ESM.avi
Video 2: final angiographic result at left anterior descending artery after percutaneous coronary intervention (AVI 1660 kb)
Rights and permissions
About this article
Cite this article
Linares Vicente, J.A., Ruiz Arroyo, J.R., Simó Sánchez, B. et al. Extremely late (7 years) paclitaxel-eluting stent thrombosis. Cardiovasc Interv and Ther 30, 176–178 (2015). https://doi.org/10.1007/s12928-014-0270-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12928-014-0270-8